How Much Upside is Left in Paragon 28, Inc. (FNA)? Wall Street Analysts Think 52.58%

15.11.24 15:55 Uhr

Werte in diesem Artikel
Aktien

9,25 EUR -0,35 EUR -3,65%

1,72 EUR 0,09 EUR 5,52%

Indizes

1.695,7 PKT -5,0 PKT -0,30%

7.709,6 PKT -26,1 PKT -0,34%

3.761,2 PKT -18,2 PKT -0,48%

Paragon 28, Inc. (FNA) closed the last trading session at $9.70, gaining 76.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $14.80 indicates a 52.6% upside potential.The average comprises five short-term price targets ranging from a low of $12 to a high of $20, with a standard deviation of $3.56. While the lowest estimate indicates an increase of 23.7% from the current price level, the most optimistic estimate points to a 106.2% upside. More than the range, one should note the standard deviation here, as it helps understand the variability of the estimates. The smaller the standard deviation, the greater the agreement among analysts.While the consensus price target is a much-coveted metric for investors, solely banking on this metric to make an investment decision may not be wise at all. That's because the ability and unbiasedness of analysts in setting price targets have long been questionable.However, an impressive consensus price target is not the only factor that indicates a potential upside in FNA. This view is strengthened by the agreement among analysts that the company will report better earnings than what they estimated earlier. Though a positive trend in earnings estimate revisions doesn't give any idea as to how much the stock could surge, it has proven effective in predicting an upside.Here's What You May Not Know About Analysts' Price TargetsAccording to researchers at several universities across the globe, a price target is one of many pieces of information about a stock that misleads investors far more often than it guides. In fact, empirical research shows that price targets set by several analysts, irrespective of the extent of agreement, rarely indicate where the price of a stock could actually be heading.While Wall Street analysts have deep knowledge of a company's fundamentals and the sensitivity of its business to economic and industry issues, many of them tend to set overly optimistic price targets. Are you wondering why?They usually do that to drum up interest in shares of companies that their firms either have existing business relationships with or are looking to be associated with. In other words, business incentives of firms covering a stock often result in inflated price targets set by analysts.However, a tight clustering of price targets, which is represented by a low standard deviation, indicates that analysts have a high degree of agreement about the direction and magnitude of a stock's price movement. While that doesn't necessarily mean the stock will hit the average price target, it could be a good starting point for further research aimed at identifying the potential fundamental driving forces.That said, while investors should not entirely ignore price targets, making an investment decision solely based on them could lead to disappointing ROI. So, price targets should always be treated with a high degree of skepticism.Here's Why There Could be Plenty of Upside Left in FNAAnalysts' growing optimism over the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates higher, could be a legitimate reason to expect an upside in the stock. That's because empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.The Zacks Consensus Estimate for the current year has increased 1% over the past month, as one estimate has gone higher compared to no negative revision.Moreover, FNA currently has a Zacks Rank #2 (Buy), which means it is in the top 20% of more than the 4,000 stocks that we rank based on four factors related to earnings estimates. Given an impressive externally-audited track record, this is a more conclusive indication of the stock's potential upside in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Therefore, while the consensus price target may not be a reliable indicator of how much FNA could gain, the direction of price movement it implies does appear to be a good guide.Must-See: Solar Stocks Poised to SkyrocketThe solar industry stands to bounce back as tech companies and the economy transition away from fossil fuels to power the AI boom.Trillions of dollars will be invested in clean energy over the coming years – and analysts predict solar will account for 80% of the renewable energy expansion. This creates an outsized opportunity to profit in the near-term and for years to come. But you have to pick the right stocks to get into.Discover Zacks’ hottest solar stock recommendation FREE.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Paragon 28, Inc. (FNA): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Paragon 28

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Paragon 28

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu paragon GmbH & Co. KGaA

Analysen zu paragon GmbH & Co. KGaA

DatumRatingAnalyst
06.12.2012paragon buyClose Brothers Seydler Research AG
04.12.2012paragon kaufenDr. Kalliwoda Research GmbH
04.09.2012paragon buyClose Brothers Seydler Research AG
29.08.2012paragon kaufenDr. Kalliwoda Research GmbH
11.06.2012paragon kaufenDer Aktionär
DatumRatingAnalyst
06.12.2012paragon buyClose Brothers Seydler Research AG
04.12.2012paragon kaufenDr. Kalliwoda Research GmbH
04.09.2012paragon buyClose Brothers Seydler Research AG
29.08.2012paragon kaufenDr. Kalliwoda Research GmbH
11.06.2012paragon kaufenDer Aktionär
DatumRatingAnalyst
22.05.2007paragon holdneue märkte
21.11.2006paragon DowngradeAC Research
10.11.2006paragon investiert bleibenExtraChancen
29.08.2006paragon dabeibleibenExtraChancen
11.08.2006paragon investiert bleibenExtraChancen
DatumRatingAnalyst
06.10.2009paragon verkaufenIndependent Research GmbH
14.11.2006paragon sellneue märkte
01.03.2005paragon: SellMerck Finck & Co

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für paragon GmbH & Co. KGaA nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"